동향
동향 내용
Gender Differences in the Hepatic Elimination and Pharmacokinetics of Lobeglitazone in Rats.
분류 pharmacokinetics 조회 1314
발행년도 2015 등록일 2015-09-20
출처 Biopharm Drug Dispos (바로가기)
The pharmacokinetics of lobeglitazone (LB) was studied after intravenous administration of a dose at 1 mg/kg and oral administration of doses at 0.1, 1 and 10 mg/kg in male and female rats. The area under the plasma concentration-time curve from time zero to infinity (AUCinf ) after intravenous administration was approximately 7.1 times higher in female rats than in male rats. In addition, the AUCinf in the case of oral administration was at least 4.4 times higher in female rats and appeared to increase in proportion to the dose in both genders. The in vitro half-lives were 18.8 ± 4.45 min and 60.7 ± 11.2 min, as evidenced by incubating liver microsomes obtained from male and female rats, respectively.
 
(후략)

목록



[추천 메일 발송]
추천 메일 발송
받는 분 이메일 @
추천인
리스트 이전글과 다음글
이전글이전글 Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemia.
다음글다음글 Pharmacokinetics of IDX184, a liver-targeted oral prodrug of 2'-methylguanosine-5'-monophosphate, in the monkey and formulation optimization for human exposure.